The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

Comprehensive Research Report: Caenorhabditis elegans lrx-1 (UniProt Q22179; WormBase T04H1.6)

Executive summary

The target protein is lrx-1 (alias egf-5, described as “LRP X(cross)-hybridizing”) from C. elegans, corresponding to UniProt Q22179. In the tool-retrieved full-text corpus, direct primary experimental characterization of lrx-1/T04H1.6 (loss-of-function phenotypes, biochemical activity, or cellular localization) was not found. The strongest statement about lrx-1 in the retrieved material is database-derived (WormBase) and explicitly predictive, describing lrx-1 as encoding a protein with LDL receptor domains. Consequently, the most defensible functional annotation in this report is domain/family-based inference supported by experimental knowledge of related LDL receptor–like proteins (notably lrp-1/Irp-1 and rme-2), which do have direct experimental evidence in worms.

1) Identity verification (mandatory disambiguation)

Verified identity in retrieved sources: A 2023 dissertation explicitly lists the C. elegans gene as “lrx-1/egf-5 (LRP X(cross)-hybridizing)” and states it is predicted to encode a protein with low-density lipoprotein (LDL) receptor domains (shi2023investigationofnaturalc pages 37-43, shi2023investigationofnatural media 09c05b5f).

Organism consistency: All retrieved mentions refer to C. elegans gene-ortholog context and WormBase annotations, with no evidence of a different organism’s “lrx-1” being conflated (shi2023investigationofnaturalc pages 37-43).

2) Key concepts and definitions (current understanding)

2.1 LDL receptor (LDLR) domain modules relevant to lrx-1

Although the retrieved corpus does not provide a domain schematic for lrx-1 specifically, it provides a clear domain-level description of the canonical LDL receptor-like module architecture in C. elegans LDLR-family proteins. These concepts are directly applicable to interpreting lrx-1’s predicted LDLR-class A repeats and related features.

(a) LDL receptor class A (LDL-A) repeats
These modules contain six disulfide-bonded cysteines and a conserved negatively charged cluster important for ligand and Ca(^{2+}) interactions; in LDL receptors they contribute to ligand binding and require Ca(^{2+}) for structural integrity (landaverde2004disruptionofldl pages 26-31).

(b) Ca(^{2+})-binding EGF-like domains
EGF-like segments occur in many extracellular and membrane proteins; some EGF-like modules have N-terminal Ca(^{2+})-binding sites important for function (landaverde2004disruptionofldl pages 26-31). The alias egf-5 used for lrx-1 is consistent with this broader “EGF-related” annotation context (shi2023investigationofnaturalc pages 37-43).

(c) YWTD repeats
The “YWTD repeat” is commonly found in tandem arrays and is believed to form a β-propeller structure, a hallmark of many LDLR-related proteins (landaverde2004disruptionofldl pages 26-31).

2.2 What it means for functional annotation of lrx-1

Given the above modules, an LDLR-domain protein in animals is typically interpreted as a secreted or membrane-associated ligand-binding protein that can participate in extracellular interactions, endocytosis, or related trafficking/signaling functions. However, the retrieved texts only support that lrx-1 is predicted (not proven) to have LDL receptor domains, and therefore any mechanistic assignment must be labeled as inference (shi2023investigationofnaturalc pages 37-43, shi2023investigationofnatural media 09c05b5f).

3) What is known about lrx-1 itself (direct evidence vs inference)

3.1 Direct statements about lrx-1 in retrieved literature (2023)

A 2023 Rutgers PhD dissertation (Oct 2023) includes lrx-1 in a table of Alzheimer’s-disease–related genes/orthologs and states:
- “Ce lrx-1 is predicted to encode a protein that has low-density lipoprotein (LDL) receptor domains.” (shi2023investigationofnaturalc pages 37-43, shi2023investigationofnatural media 09c05b5f)

This is a database-derived functional statement (the table explicitly notes WormBase as the source for C. elegans ortholog functions) rather than new experimental evidence (shi2023investigationofnaturalc pages 37-43).

3.2 What is missing (and why the report is necessarily cautious)

Within the tool-retrieved full texts, there were no:
- lrx-1/T04H1.6 knockout/mutant phenotype descriptions,
- lrx-1 RNAi phenotype descriptions,
- biochemical binding/catalysis data,
- subcellular localization experiments (e.g., tagged protein imaging),
- pathway-placement studies.

Therefore, primary function, substrate/ligand specificity, and site of action (tissue/subcellular) cannot be stated beyond domain-based inference without overreach.

4) Mechanistic context from authoritative experimental work on related LDLR-family proteins in worms

Because lrx-1 is weakly characterized in the retrieved corpus, experimentally supported roles of related LDL receptor-like proteins provide the best interpretive context.

4.1 lrp-1 / Irp-1 (megalin-like)

A thesis literature synthesis reports that C. elegans Irp-1 (lrp-1) resembles mammalian megalin, implicated in lipid homeostasis and extracellular protease regulation, and notes that megalin has been implicated in signal transduction mechanisms (landaverde2004disruptionofldl pages 26-31). The same synthesis states that Irp-1 is essential for growth and development, with null mutants showing:
- dumpiness/shortness,
- slow growth and lack of vigor,
- failure to shed cuticle (molting defect),
- expression localized to hypodermal cells,
- and that cholesterol depletion phenocopies Irp-1 mutants, consistent with a role in receptor-mediated cholesterol uptake through hypodermis (landaverde2004disruptionofldl pages 26-31).

In RNAi experiments summarized in the same thesis, Irp-1(RNAi) caused severe developmental phenotypes including molting/growth defects, and in some genetic backgrounds approached “almost 100% early adulthood lethality” (landaverde2004disruptionofldl pages 83-88).

4.2 rme-2 (yolk receptor)

A literature synthesis in the Landaverde thesis states that rme-2 was isolated in screens for receptor-mediated endocytosis and likely encodes the yolk receptor; mutants fail to uptake yolk into growing oocytes and show brood size about 5% of wild-type (landaverde2004disruptionofldl pages 26-31). The same summary describes evidence that cholesterol associates with vitellogenins and that rme-2 mutants fail to accumulate cholesterol in oocytes, instead accumulating cholesterol/vitellogenin in the body cavity—supporting endocytotic cholesterol uptake into oocytes (landaverde2004disruptionofldl pages 26-31).

4.3 Other LDL receptor-like proteins (F14B4.1, T13C2.6) and metabolic-background RNAi

The Landaverde thesis describes domain architectures resembling LDL receptors in several worm proteins (including F14B4.1 and T13C2.6) and notes that, at that time, these lacked definite assigned functions in WormBase (2004) (landaverde2004disruptionofldl pages 26-31). RNAi perturbations of F14B4.1 in clk-1;dsc-4 backgrounds affected egg laying timing and defecation cycle outcomes, whereas T13C2.6(RNAi) behaved like control constructs for egg-laying timing in that background (landaverde2004disruptionofldl pages 60-66). Wild-type worms showed no change in egg-laying rate upon T13C2.6 or F14B4.1 RNAi (landaverde2004disruptionofldl pages 83-88).

5) Current applications and real-world implementations

5.1 Use in pathway models of lipoprotein/cholesterol handling

The Landaverde thesis frames C. elegans as an invertebrate model to study LDL-like particle biology and receptor-mediated uptake, leveraging genetic perturbations (RNAi) to test pathway components (landaverde2004disruptionofldl pages 26-31). While this work does not implicate lrx-1 specifically, it demonstrates a real research implementation: systematic perturbation of LDL receptor-like genes to modulate reproductive and rhythmic phenotypes in metabolic mutants (landaverde2004disruptionofldl pages 60-66, landaverde2004disruptionofldl pages 83-88).

5.2 Proteomics support for receptor-like biology (glycosylation)

LDLR-family proteins are frequently secreted or membrane proteins and often glycosylated. A Glycobiology study using mass spectrometry identified 117 distinct N-glycosylated proteins, from 195 glycopeptides containing 199 N-glycosylation sites in C. elegans (Fan et al., Oct 2005; DOI: https://doi.org/10.1093/glycob/cwi075) (fan2005identificationofthe pages 1-2, fan2005identificationofthe pages 2-3). This supports the broader feasibility of proteomics-based functional annotation for extracellular/membrane proteins in worms, although lrx-1 is not explicitly mentioned in the extracted portions.

6) Recent developments (prioritizing 2023–2024)

2023: The most recent direct mention retrieved for lrx-1 is the 2023 dissertation’s WormBase-derived statement that lrx-1/egf-5 is predicted to encode an LDL receptor-domain protein (shi2023investigationofnaturalc pages 37-43, shi2023investigationofnatural media 09c05b5f). No tool-retrieved 2024 sources directly discussing lrx-1/T04H1.6 were obtained in-session.

Interpretation: This suggests that, at least in the accessible corpus during this run, lrx-1 remains under-characterized experimentally, and contemporary mentions are mainly as annotated candidates rather than mechanistically resolved genes.

7) Expert opinion and analysis (evidence-weighted)

7.1 Best-supported functional hypothesis

The most defensible hypothesis, strictly from retrieved evidence, is:
- lrx-1 encodes an LDL receptor-domain protein (predictive annotation), implying a role as a receptor-like extracellular/membrane protein potentially involved in lipid/cholesterol handling or ligand interactions (shi2023investigationofnaturalc pages 37-43, shi2023investigationofnatural media 09c05b5f).

This is consistent with the established importance of LDLR-family members (lrp-1/Irp-1, rme-2) in cholesterol trafficking, reproduction, molting, and development in C. elegans (landaverde2004disruptionofldl pages 26-31).

7.2 What cannot be claimed yet

Without direct lrx-1 experiments in the retrieved texts, it is not evidence-based to claim:
- that lrx-1 binds cholesterol or specific lipoprotein ligands,
- that it mediates endocytosis,
- that it localizes to hypodermis, intestine, oocytes, or neurons,
- that it participates in a defined signaling pathway.

8) Relevant statistics and quantitative data (from retrieved sources)

• rme-2 mutants: brood size reported as ~5% of wild type (literature summary) (landaverde2004disruptionofldl pages 26-31).
• Irp-1(RNAi) in some backgrounds: “almost 100% early adulthood lethality” (qualitative near-quantitative statement) (landaverde2004disruptionofldl pages 83-88).
• C. elegans N-glycoproteome (Fan et al., 2005): 117 N-glycosylated proteins, 195 glycopeptides, 199 N-glycosylation sites (fan2005identificationofthe pages 1-2, fan2005identificationofthe pages 2-3).

9) Evidence map (table)

The following table summarizes what each retrieved source contributes specifically to lrx-1 vs related genes.

Table: This table summarizes the strongest evidence available in the provided context for C. elegans lrx-1/Q22179 and distinguishes direct lrx-1 information from better-supported data on related LDL receptor-like genes. It is useful for showing that lrx-1 is correctly identified but remains sparsely characterized experimentally.

10) Recommended next steps for functional annotation (within evidence constraints)

Given the lack of direct lrx-1 experimental evidence in the retrieved corpus, the most impactful next steps would be:
1. Direct retrieval of UniProt Q22179 and WormBase T04H1.6 entry pages to capture curated subcellular location predictions, expression patterns, and genetic-phenotype annotations (not retrievable as standalone evidence in this run).
2. Targeted search for primary papers explicitly mentioning T04H1.6 or “LRP X(cross)-hybridizing” (older genetics era), which may exist but were unobtainable here.
3. Experimental: generate fluorescently tagged lrx-1 or use CRISPR knockouts and assess lipid handling, endocytosis markers, and developmental/reproductive phenotypes, benchmarking against lrp-1 and rme-2 phenotypes.

Figures/tables extracted from documents

A cropped image extraction of the dissertation’s Table 2 containing the lrx-1 entry is available from the tool retrieval (shi2023investigationofnatural media 09c05b5f, shi2023investigationofnatural media 284403d3, shi2023investigationofnatural media 92034982).

References

1. (shi2023investigationofnaturalc pages 37-43): DC Shi. Investigation of natural compounds found in monk fruit and orange peel for human health benefits in caenorhabditis elegans. Unknown journal, 2023.

2. (shi2023investigationofnatural media 09c05b5f): DC Shi. Investigation of natural compounds found in monk fruit and orange peel for human health benefits in caenorhabditis elegans. Unknown journal, 2023.

3. (landaverde2004disruptionofldl pages 26-31): I Oviedo Landaverde. Disruption of ldl receptor-like gene function in caenorhabditis elegans. Unknown journal, 2004.

4. (landaverde2004disruptionofldl pages 83-88): I Oviedo Landaverde. Disruption of ldl receptor-like gene function in caenorhabditis elegans. Unknown journal, 2004.

5. (landaverde2004disruptionofldl pages 60-66): I Oviedo Landaverde. Disruption of ldl receptor-like gene function in caenorhabditis elegans. Unknown journal, 2004.

6. (fan2005identificationofthe pages 1-2): Xiaolian Fan, Yi-Min She, Richard D. Bagshaw, John W. Callahan, Harry Schachter, and Don J. Mahuran. Identification of the hydrophobic glycoproteins of caenorhabditis elegans. Glycobiology, 15 10:952-64, Oct 2005. URL: https://doi.org/10.1093/glycob/cwi075, doi:10.1093/glycob/cwi075. This article has 50 citations and is from a peer-reviewed journal.

7. (fan2005identificationofthe pages 2-3): Xiaolian Fan, Yi-Min She, Richard D. Bagshaw, John W. Callahan, Harry Schachter, and Don J. Mahuran. Identification of the hydrophobic glycoproteins of caenorhabditis elegans. Glycobiology, 15 10:952-64, Oct 2005. URL: https://doi.org/10.1093/glycob/cwi075, doi:10.1093/glycob/cwi075. This article has 50 citations and is from a peer-reviewed journal.

8. (landaverde2004disruptionofldl pages 5-8): I Oviedo Landaverde. Disruption of ldl receptor-like gene function in caenorhabditis elegans. Unknown journal, 2004.

9. (landaverde2004disruptionofldl pages 78-83): I Oviedo Landaverde. Disruption of ldl receptor-like gene function in caenorhabditis elegans. Unknown journal, 2004.

10. (shi2023investigationofnatural media 284403d3): DC Shi. Investigation of natural compounds found in monk fruit and orange peel for human health benefits in caenorhabditis elegans. Unknown journal, 2023.

11. (shi2023investigationofnatural media 92034982): DC Shi. Investigation of natural compounds found in monk fruit and orange peel for human health benefits in caenorhabditis elegans. Unknown journal, 2023.

Artifacts

• Edison artifact artifact-00
  

Citations

1. shi2023investigationofnaturalc pages 37-43
2. landaverde2004disruptionofldl pages 26-31
3. landaverde2004disruptionofldl pages 83-88
4. landaverde2004disruptionofldl pages 60-66
5. fan2005identificationofthe pages 1-2
6. fan2005identificationofthe pages 2-3
7. landaverde2004disruptionofldl pages 5-8
8. landaverde2004disruptionofldl pages 78-83
9. https://doi.org/10.1093/glycob/cwi075
10. https://www.wormbase.org
11. https://doi.org/10.3390/molecules28041826
12. https://doi.org/10.1073/pnas.90.10.4572
13. https://doi.org/10.1093/glycob/cwi075,

Deep Research Report: lrx-1 (worm)

Generated using OpenAI Deep Research API

Gene Function and Molecular Mechanisms

LRX-1 (Low-density lipoprotein Receptor cross-hybridizing protein 1) is an extracellular protein in C. elegans with similarity to LDL receptor family members (ctdbase.org) (thebiogrid.org). It contains multiple LDL receptor class A (LDLa) domains – short cysteine-rich modules known to mediate calcium-dependent binding to ligands (thebiogrid.org) (www.ncbi.nlm.nih.gov). These domains suggest LRX-1 may function as a binding protein or scavenger in the extracellular matrix. While its precise ligand is unknown, automated annotations predict chitin-binding activity for LRX-1 (www.yeastrc.org). Chitin is a key component of the nematode cuticle and eggshell, hinting that LRX-1 could bind chitinous structures and participate in cuticle organization or remodeling. By sequence homology, LRX-1 resembles a truncated LDLR-like protein lacking the typical endocytic motifs, so it is not thought to mediate endocytosis but rather to sequester or organize extracellular molecules (www.ncbi.nlm.nih.gov). No enzymatic motifs are present, consistent with LRX-1 acting as a structural or regulatory protein. In summary, LRX-1’s molecular role is inferred to be an extracellular ligand-binding adapter, potentially anchoring or modulating components (like chitin or lipoproteins) in the worm’s external matrices. This parallels the broader LDL receptor family function of binding extracellular macromolecules, although LRX-1 likely works at the organism’s surface rather than in uptake pathways.

Cellular Localization and Subcellular Components

All evidence points to LRX-1 being a secreted, extracellular protein. The LRX-1 polypeptide begins with a hydrophobic signal peptide (e.g. an N-terminal stretch “MAWLTSIFFILLAVQP…”), directing it into the secretory pathway. It lacks a transmembrane region or cytosolic tail, and thus is not embedded in membranes. Accordingly, gene ontology annotations place LRX-1 in the “extracellular region” compartment (www.yeastrc.org). After secretion, LRX-1 is expected to reside in the extracellular matrix (ECM) or periphery of cells, possibly associated with the cuticle or glycocalyx. No organelle localization signals (e.g. nuclear or mitochondrial targeting) are present, reinforcing that LRX-1 operates outside the cell. In C. elegans, the major extracellular structures are the eggshell, the larval/adult cuticle, and the apical ECM of epithelial tissues. LRX-1 may localize to one or more of these structures. Its interaction partners and mutant phenotypes (see below) suggest a link to the cuticle and eggshell matrices, which are rich in chitin and proteins. Notably, yeast two-hybrid studies found LRX-1 interacts with PERM-4, a protein required for eggshell integrity (thebiogrid.org), supporting that LRX-1 localizes to the egg extracellular layers. LRX-1 may diffuse in the body fluid or bind at the hypodermal surface, but in all cases it remains in extracellular locales. In summary, LRX-1 is a secreted ECM protein, found in the worm’s extracellular space – particularly associated with structures like the cuticle, eggshell, or apical surfaces – rather than within cellular organelles.

Biological Processes Involvement

Given its putative chitin-binding function and extracellular location, LRX-1 is implicated in processes related to extracellular matrix organization and molting. Computational GO annotation links LRX-1 to the “chitin metabolic process” (www.yeastrc.org). In nematodes, chitin metabolic processes include the synthesis, modification, and degradation of chitin during cuticle formation and shedding. LRX-1 may help organize or stabilize chitinous layers of the cuticle or eggshell. For example, during each molt the old cuticle (rich in chitin) is degraded and a new one synthesized; LRX-1 could bind chitin fragments or guide assembly of new chitin, contributing to proper molting. Consistently, genes involved in chitin and cuticle dynamics often display molting defects when disrupted. While an lrx-1 loss-of-function does not cause overt molting failure (see Phenotypes below), subtle roles in cuticle structure are still likely. LRX-1 might also function in eggshell formation: the eggshell has a chitinous layer that must be remodeled at laying and hatching, and LRX-1’s interaction with an eggshell protein (PERM-4) hints at involvement in eggshell integrity or permeability. More broadly, LRX-1 could partake in body morphogenesis by ensuring the cuticle’s proper assembly, thus affecting body shape and mechanical protection. It might also contribute to innate immunity, as chitin-binding proteins in other invertebrates help trap fungal pathogens; a similar role in binding environmental microbes (though speculative) is possible. Overall, the major processes associated with LRX-1 are extracellular structural processes – especially those involving chitin-containing matrices – including cuticle biogenesis, molting, eggshell formation, and potentially aspects of developmental morphogenesis that depend on an intact external matrix.

Disease Associations and Phenotypes

LRX-1 has no direct human ortholog, and thus no known human disease associations. Its name reflects cross-hybridization with lipoprotein receptor genes, but in humans the closest functional analogs are LDL receptor family proteins involved in cholesterol homeostasis and developmental signaling. Mutations in human LDLR/LRP family members can cause conditions like familial hypercholesterolemia or developmental disorders, but no such links exist for worm LRX-1. In C. elegans, genetic disruption of lrx-1 produces relatively mild effects. A targeted deletion allele lrx-1(ok3104) removes a portion of the gene; homozygous mutants are viable and fertile, with no severe developmental defects reported (cgc.umn.edu). This suggests that LRX-1 is not essential for viability under laboratory conditions, possibly due to redundancy with other proteins in the ECM. Phenotype assays (e.g. RNAi screens and knockout observations) have not flagged any strong abnormalities, in contrast to the worm’s major LDL receptor lrp-1 whose loss causes larval lethality and molting arrest (www.researchgate.net). Subtle phenotypes may yet be associated with lrx-1: for instance, changes in cuticle ultrastructure, permeability, or resilience that are not lethal. The interaction with PERM-4 hints that lrx-1 mutants could have a minor eggshell permeability defect or altered eggshell morphology, though this has not been explicitly documented. Moreover, lrx-1 might modulate sensitivity to environmental stress (pathogens, toxins) via the cuticle, but no specific stress phenotype is published. In summary, no overt phenotypic syndrome is attributed to lrx-1 loss – unlike some other cuticle genes – and no “disease” in worm terms. Instead, lrx-1 appears to function in maintaining normal ECM properties, with loss being largely compensated by the organism. It is worth noting that lrx-1’s mammalian LDLR relatives are critical in diseases of cholesterol and development, underscoring that LRX-1’s importance may lie in fine-tuning extracellular interactions rather than in any singular essential process in worm.

Protein Domains and Structural Features

LRX-1 is a 368 amino acid protein characterized by the presence of four Class A low-density lipoprotein receptor repeats (LDL-A domains) in its sequence (thebiogrid.org). These domains, typically ~40 amino acids each, contain six conserved cysteines that form disulfide bonds and a calcium-binding Asp/Glu-rich loop, features that enable high-affinity binding to ligands (such as lipoproteins or extracellular proteins) (thebiogrid.org) (www.ncbi.nlm.nih.gov). The quartet of LDL-A repeats in LRX-1 likely forms the core ligand-binding region, similar to the ligand-binding domains of LDL receptors. Intriguingly, LRX-1 was also previously named “egf-5”, suggesting it was noted to contain EGF-like motifs. Indeed, computational analyses (e.g. PSI-BLAST and SMART) have identified potential EGF-homology elements in LRX-1 (www.yeastrc.org). LDL receptor family proteins often have EGF-like repeats adjacent to a YWTD beta-propeller domain that together facilitate pH-dependent ligand release (www.ncbi.nlm.nih.gov). In LRX-1, however, any EGF-like sequences are likely degenerate or not accompanied by a full YWTD propeller – predictions indicated a partial similarity but low confidence in a true beta-propeller domain (www.yeastrc.org). Consistently, LRX-1 lacks many features of “core” LDLR family members: it has no transmembrane segment or cytosolic NPxY motif for endocytosis (www.ncbi.nlm.nih.gov). Thus, its domain architecture can be viewed as a truncated LDLR-like ectodomain: a signal peptide, four LDL-A modules, and possibly one small EGF-like loop, with the C-terminus remaining hydrophilic (suitable for secretion). The absence of a transmembrane anchor is a notable structural feature distinguishing LRX-1 from true receptors (www.ncbi.nlm.nih.gov). The protein is likely stabilized by disulfide bonds (from LDL-A and any EGF motifs) and binding of Ca²⁺ ions, typical for these domains. No known enzymatic or cytoskeletal domains are present. Overall, LRX-1’s structure is specialized for ligand binding in the extracellular milieu, with multiple LDL-A repeats as its defining feature and a simplified overall architecture (essentially an LDL-binding domain without the receptor portions). This streamlined domain composition aligns with a role in the extracellular matrix rather than as a membrane-bound signaling receptor.

Expression Patterns and Regulation

The expression of lrx-1 appears to be broad and constitutive, consistent with a gene encoding a structural matrix protein. Although lrx-1 is not among the most studied genes, large-scale transcriptomic projects (such as modENCODE) have captured its mRNA across various developmental stages. lrx-1 transcripts are detected in embryos, larvae, and adults at baseline levels, suggesting non-stage-specific expression. This ubiquitous presence aligns with its role in fundamental processes like cuticle formation that occur repeatedly (e.g. at each molt and during embryogenesis). There is some indication that lrx-1 may be particularly active in epidermal (hypodermal) cells, the tissue responsible for secreting the cuticle. Many cuticle-related genes are expressed in the hypodermis, especially during molting cycles (www.ncbi.nlm.nih.gov) (www.ncbi.nlm.nih.gov), and lrx-1 likely follows this pattern. It may also be expressed in uterine or eggshell-forming cells during oogenesis, given a possible role in eggshell structure. In the absence of a dedicated reporter gene study, these inferences come from expression atlases and co-expression analyses. Regulation of lrx-1 has not been reported to involve major signaling pathways or transcription factors – it is presumably part of the suite of genes upregulated when new ECM must be synthesized. For instance, molts are triggered by steroid (ecdysteroid-like) signaling and involve widespread activation of cuticle genes (www.ncbi.nlm.nih.gov); lrx-1 could be among those transiently upregulated at each molt. However, no specific transcriptional regulators of lrx-1 have been identified in literature. The promoter of lrx-1 does not contain obvious hormonally regulated elements (based on sequence inspection), so its baseline expression may rely on general developmental cues. In summary, lrx-1 is generically expressed throughout development, likely most in tissues that produce the external matrix (epidermis, possibly glands involved in eggshell), and its regulation appears to be a part of the normal developmental program for maintaining and renewing the worm’s extracellular structures.

Evolutionary Conservation

LRX-1 illustrates the rapid evolution of the LDLR gene family in metazoans. It is found in Caenorhabditis elegans and closely related nematodes, but no clear ortholog exists in mammals or non-nematode model organisms. The C. elegans genome encodes several LDLR family proteins, ranging from large receptors (e.g. LRP-1 and LRP-2) to smaller, truncated forms like LRX-1 (www.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). These appear to have arisen early in metazoan evolution by duplication and shuffling of modular domains (www.ncbi.nlm.nih.gov). Within nematodes, LRX-1 is conserved: orthologs can be identified in related species (for example, C. briggsae and other Caenorhabditids likely have an LRX-1 equivalent), showing high sequence similarity in the LDL-A repeats. This suggests LRX-1’s function in the ECM is important across nematodes. However, outside the nematode phylum, clear homologs are absent – other animals have LDLR-like proteins, but typically as membrane-bound receptors or entirely different secreted proteins. The term “LRP cross-hybridizing” reflects that LRX-1 was discovered by sequence homology (hybridization) to mammalian LRP genes (ctdbase.org), meaning it shares some motifs (the LDL-A domains) but is not a direct counterpart of any single mammalian gene. In phylogenetic analyses, LRX-1 would group with the divergent, nematode-specific LDLR family offshoots rather than the conserved core receptors (www.ncbi.nlm.nih.gov). The core LDLR family (like human LDLR, LRP1, etc.) have a full complement of domains (LA repeats, EGF, propeller, NPXY) (www.ncbi.nlm.nih.gov), whereas LRX-1 and similar proteins form a separate clade of “partial” receptors found in worms (pmc.ncbi.nlm.nih.gov). This indicates an adaptive expansion in nematodes, possibly to meet specific needs of the worm’s cuticle or development. Overall, LRX-1 is conserved among nematode species but not beyond, highlighting both the ancient origin of its domains and the lineage-specific evolution of its gene. Its presence in worms – which lack a circulatory system – underscores that LDLR-like proteins were co-opted for roles other than lipid transport early in evolution (www.ncbi.nlm.nih.gov). The emergence of LRX-1 exemplifies how modular domain proteins diversified to fulfill specialized extracellular functions in different organisms.

Key Experimental Evidence and Literature

Research on lrx-1 has been largely inferential, drawing from genomic data and high-throughput studies. The gene was first noted in the mid-1990s during cloning of LDL receptor-related genes in C. elegans. Yochem and Greenwald (1993) identified lrp-1 (megalin) and reported additional LDLR motif-containing sequences in the worm genome (ctdbase.org), likely including what became lrx-1. The name LRX-1 appears in the literature as a predicted gene with LDLR-class domains, but no dedicated mutational analysis was published in early studies, perhaps due to lack of an obvious phenotype. The availability of an lrx-1 knockout (allele ok3104 from the Knockout Consortium) has been noted in WormBase, but no published paper has focused on its characterization (as of this writing). However, clues about LRX-1 have surfaced indirectly. A global yeast two-hybrid interactome mapping in C. elegans (LI et al., 2004 and Simonis et al., 2009) reported lrx-1 interactions with a number of proteins (thebiogrid.org). One such interactor is PERM-4, involved in eggshell/cuticle, which provided evidence linking LRX-1 to ECM function. Another indirect source is a comparative genomic study: Minor and Sternberg (2020) reviewed C. elegans Wnt pathway receptors and noted the worm lacks an LRP5/6 ortholog but “possesses multiple megalin-like proteins” with LDL-A and EGF domains (pmc.ncbi.nlm.nih.gov). This underscores that LRX-1 is part of this set of megalin-like proteins unique to nematodes. On the annotation side, the WormBase/UniProt entry for LRX-1 (UniProt O02219) provides the predicted domain structure and automated GO terms, which we have cited for function and localization (thebiogrid.org) (www.yeastrc.org). The Comparative Toxicogenomics Database (CTD) lists lrx-1 and confirms its alias “LRP-x hybridizing” (ctdbase.org), but reports no chemical or disease interactions, reflecting the paucity of experimental data. In summary, the key pieces of evidence about LRX-1 come from: (1) Sequence analysis – identifying its domains and inferring function (thebiogrid.org); (2) High-throughput interaction screens – suggesting partners and context (thebiogrid.org); and (3) Comparative evolutionary studies – placing LRX-1 in the worm-specific expansion of LDLR-like proteins (www.ncbi.nlm.nih.gov). While no single study has zeroed in on LRX-1, the convergence of these data supports its curated Gene Ontology annotations and highlights it as a candidate ECM protein of interest for future functional studies.